Page last updated: 2024-10-25

eflornithine and Epithelial Ovarian Cancer

eflornithine has been researched along with Epithelial Ovarian Cancer in 1 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (ODC), has promising activity against various cancers and a tolerable safety profile for long-term use as a chemopreventive agent."1.62Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer. ( Hwang, WY; Kim, K; Kim, YB; No, JH; Park, WH; Suh, DH, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hwang, WY1
Park, WH1
Suh, DH1
Kim, K1
Kim, YB1
No, JH1

Other Studies

1 other study available for eflornithine and Epithelial Ovarian Cancer

ArticleYear
Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer.
    International journal of molecular sciences, 2021, Sep-23, Volume: 22, Issue:19

    Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma, Ovarian Epithelial; Caspase 3; Cell Line, Tumor; C

2021